Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZDHHC21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZDHHC14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KBTBD11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LTBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF74 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C3orf70 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCML1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRKAR1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARD6G-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CFD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITSN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FZD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BSPRY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TADA2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC6A15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on